Literature DB >> 9113941

Morbidity and mortality of open lung biopsy in children.

L Davies1, S Dolgin, M Kattan.   

Abstract

OBJECTIVE: In patients with diffuse pulmonary infiltrates, when empiric therapy or less-invasive diagnostic procedures fail, physicians frequently resort to open lung biopsy (OLB) to provide a definite diagnosis and to help redirect therapeutic treatment. OLB is still widely regarded as a safe diagnostic procedure, even in the critically ill child. The objective of this study is to evaluate the accuracy of this view with regard to children with acute respiratory failure (ARF) and, for this purpose, compares the mortality and morbidity of such patients with those without ARF.
DESIGN: Retrospective chart review.
SETTING: University hospital. PATIENTS: Forty-two patients (mean age, 6.6 years) underwent 47 OLBs for undiagnosed diffuse pulmonary infiltrates between July 1984 and December 1994. Twenty-six patients (55%) were in ARF. Fifteen of these patients were intubated and receiving mechanical ventilatory support before the OLB procedure.
RESULTS: The overall incidence of serious complications associated with the OLB procedure was 51%. Of the patients with ARF, 17 (65%) had at least one major complication compared with 3 (14%) of the patients without ARF. Pleural air complications (62% of the total) occurred only in patients with ARF: pneumothoraces and/or prolonged air leaks developed in 10 (38%) after their OLBs; 9 of these patients died, and 7 had pneumothorax complicating their chest tube removal, which required replacement chest tubes. All patients with ARF preoperatively required prolonged ventilatory support after the OLB procedure, whereas 90% of the patients without ARF could be extubated within 24 hours. Overall, 10 patients (24%) died after the OLB procedure. All deaths occurred in patients with ARF. Both ARF preoperatively and the presence of postoperative complications were significantly associated with decreased survival.
CONCLUSIONS: The morbidity and mortality rates of children with ARF undergoing OLB for diffuse pulmonary infiltrates differ considerably from those of children without ARF. For children with ARF, OLB is associated with the risk of prolonged ventilatory support, recurrent pneumothoraces, and air leaks. These complications may be attributable to such patients' having diseased lungs with poor healing. Moreover, these complications may, in turn, contribute to the patients' poor outcomes.

Entities:  

Mesh:

Year:  1997        PMID: 9113941     DOI: 10.1542/peds.99.5.660

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Evaluation of chronic infectious interstitial pulmonary disease in children by low-dose CT-guided transthoracic lung biopsy.

Authors:  Christoph M Heyer; Stefan P Lemburg; Thomas Kagel; Klaus-Michael Mueller; Thomas G Nuesslein; Christian H L Rieger; Volkmar Nicolas
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

2.  A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation.

Authors:  Erin Qualter; Prakash Satwani; Angela Ricci; Zhezhen Jin; Mark B Geyer; Bachir Alobeid; Kavita Radhakrishnan; Michael Bye; William Middlesworth; Phyllis Della-Letta; Gerald Behr; Miguel Muniz; Carmella van de Ven; Lauren Harrison; Erin Morris; Mitchell S Cairo
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-23       Impact factor: 5.742

3.  Effects of an inadvertent dose of cytarabine in a child with Fanconi's anemia: reducing medication errors.

Authors:  Michael E Trigg; Vinay Nadkarni; Aaron Chidekel; Charles McKay; Rita Meek; Gregory Griffin; Maureen Edelson; Anne Reilly; Joseph Peoples; Stuart Levine; Frederick Meier
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

5.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.